| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-18 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-15 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-15 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-13 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-13 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-13 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |